Neoadjuvant Tebentafusp in Patients With Metastatic Uveal Melanoma

NCT07057596 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

19

Enrollment

OTHER

Sponsor class

Conditions

Mestastatic Uveal Melanoma

Interventions

DRUG: Tebentafusp

Sponsor

Grupo Español Multidisciplinar de Melanoma